Northern Trust Corp Celcuity Inc. Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

A detailed history of Northern Trust Corp transactions in Celcuity Inc. stock. As of the latest transaction made, Northern Trust Corp holds 189,758 shares of CELC stock, worth $3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

189,758

Previous 183,188 3.59%

Holding current value

$3 Million

Previous $2.67 Million 53.54%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$13.74 - $21.6 $90,271 - $141,912	6,570 Added 3.59%	189,758 $4.1 Million
Q4 2023 Feb 13, 2024	BUY	$8.7 - $15.02 $17,704 - $30,565	2,035 Added 1.12%	183,188 $2.67 Million
Q3 2023 Nov 13, 2023	SELL	$8.96 - $10.75 $12,284 - $14,738	-1,371 Reduced 0.75%	181,153 $1.66 Million
Q2 2023 Aug 11, 2023	BUY	$9.39 - $12.18 $1.32 Million - $1.71 Million	140,480 Added 334.13%	182,524 $2 Million
Q1 2023 May 15, 2023	BUY	$9.4 - $12.82 $26,545 - $36,203	2,824 Added 7.2%	42,044 $430,000

Q4 2022 Feb 13, 2023	SELL	$7.55 - $14.01 $1,457 - $2,703	-193 Reduced 0.49%	39,220 $549,000
Q3 2022 Nov 14, 2022	SELL	$8.0 - $10.64 $12,960 - $17,236	-1,620 Reduced 3.95%	39,413 $395,000
Q2 2022 Aug 12, 2022	SELL	$5.35 - $10.11 $359,306 - $678,987	-67,160 Reduced 62.07%	41,033 $374,000
Q1 2022 May 13, 2022	SELL	$7.93 - $13.33 $36,612 - $61,544	-4,617 Reduced 4.09%	108,193 $1.01 Million
Q4 2021 Feb 08, 2022	BUY	$11.96 - $19.35 $1,973 - $3,192	165 Added 0.15%	112,810 $1.49 Million
Q3 2021 Nov 15, 2021	BUY	$17.35 - $24.87 $173,048 - $248,053	9,974 Added 9.71%	112,645 $2.03 Million
Q2 2021 Aug 13, 2021	BUY	$14.25 - $30.93 $914,237 - $1.98 Million	64,157 Added 166.58%	102,671 $2.46 Million
Q1 2021 May 12, 2021	SELL	$10.43 - $17.8 $111,340 - $190,015	-10,675 Reduced 21.7%	38,514 $552,000
Q4 2020 Feb 11, 2021	SELL	$5.13 - $11.72 $27,265 - $62,291	-5,315 Reduced 9.75%	49,189 $451,000
Q3 2020 Nov 16, 2020	BUY	$5.1 - $7.07 $2,713 - $3,761	532 Added 0.99%	54,504 $317,000
Q2 2020 Aug 14, 2020	SELL	$4.42 - $11.04 $81,093 - $202,550	-18,347 Reduced 25.37%	53,972 $374,000
Q1 2020 May 14, 2020	BUY	$5.79 - $11.78 $42,550 - $86,571	7,349 Added 11.31%	72,319 $469,000
Q4 2019 Feb 14, 2020	BUY	$9.47 - $16.71 $75 - $133	8 Added 0.01%	64,970 $691,000
Q3 2019 Nov 13, 2019	BUY	$15.74 - $23.65 $3,132 - $4,706	199 Added 0.31%	64,962 $1.1 Million
Q2 2019 Aug 13, 2019	BUY	$19.88 - $25.0 $19,045 - $23,950	958 Added 1.5%	64,763 $1.62 Million
Q1 2019 May 13, 2019	BUY	$18.38 - $24.44 $35,234 - $46,851	1,917 Added 3.1%	63,805 $1.4 Million
Q4 2018 Feb 12, 2019	BUY	$20.87 - $29.05 $25,524 - $35,528	1,223 Added 2.02%	61,888 $1.48 Million
Q3 2018 Nov 14, 2018	BUY	$20.96 - $30.77 $62,775 - $92,156	2,995 Added 5.19%	60,665 $1.75 Million
Q2 2018 Aug 14, 2018	BUY	$16.13 - $26.99 $593,164 - $992,530	36,774 Added 175.99%	57,670 $1.43 Million
Q1 2018 May 09, 2018	BUY	$13.55 - $21.3 $59,145 - $92,974	4,365 Added 26.4%	20,896 $344,000
Q4 2017 Feb 14, 2018	BUY	$12.12 - $21.65 $200,355 - $357,896	16,531	16,531 $313,000

Others Institutions Holding CELC

# of Institutions

Shares Held

22.9M

Call Options Held

24.9K

Put Options Held

View Full List

About Celcuity Inc.

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $236M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

More about CELC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Celcuity Inc. Transaction History